Executive Summary
The Madras High Court ruled in favor of M/s.N.Ranga Rao & Sons Private Limited, finding that the defendant's use of the mark 'WOOD' constituted both trademark infringement and passing off against the plaintiff's registered word mark 'WOODS'. The court affirmed that since both marks were used for identical goods (incense sticks) within the same trade channel, deception was inevitable. Consequently, the suit was decreed, granting permanent injunctions, ordering the surrender of infringing stock, and directing the defendant to render accounts.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Madras High Court. Understanding the court's reasoning in M/s.N.Ranga Rao & Sons Private Limited vs M/s.Balarama'S Incense Pvt. Ltd. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Sporta Technologies Pvt. Ltd And Anr.vsRoberta Gaming Pvt Ltd And Anr.
The Delhi High Court addressed an application filed by Sporta Technologies regarding the domain name 'www.fandream11.com'. Following disclosure from GoDaddy, the court removed Roberta Gaming Pvt Ltd from the suit and impleaded Mr. Bapi Das as Defendant No. 1. Furthermore, the Plaintiffs were allowed to amend their plaint to seek a declaration of their mark 'DREAM11' as a 'well-known' trademark, allowing the litigation to proceed against the actual domain owner.
Raytheon CompanyvsController General Of Patents And Designs
Raytheon Company appealed the rejection of its patent application by the Assistant Controller of Patents. The appellant argued that the rejection relied on outdated guidelines (CRI Guidelines, 2016), while the newer 2017 guidelines were already in effect and did not mandate novel hardware for Section 3(k) applicability.
Frimline Private LimitedvsK-Smatco Lifesciences Private Limited
The Plaintiffs filed suit alleging that the Defendants are infringing upon their patented pharmaceutical composition, IN 382949, and also copying content from the Plaintiffs' website. The Suit Patent covers a synergistic combination of Lactoferrin and Guanosine Nucleotide for treating anaemia. Based on the prima facie evidence presented, the Court granted an ad-interim injunction restraining the Defendants from marketing or selling the infringing product 'FERROTOK PLUS', while also allowing interim protection for the Plaintiffs' copyright.
M/S. Adarsh Pharmaceutical WorksvsRhugved Pharmaceuticals
The Bombay High Court addressed a writ petition filed by M/S. Adarsh Pharmaceutical Works challenging the rejection of its application for a stay of proceedings in a related trademark suit. The petitioner argued that since their own suit regarding the same product was already pending and had an injunction, the subsequent suit filed by Rhugved Pharmaceuticals seeking passing off should be stayed under Section 10 of the CPC. The Court agreed with the petitioner's stance, directing that the District Judge-12, Nagpur, shall not proceed with Trademark Suit No.3 of 2023 in the interim.
XxvsYy
The Delhi High Court granted an ex-parte ad-interim injunction in favor of the Plaintiff (Xx) against the Defendants (Yy) concerning trademark infringement and passing off. The court found that the Defendant's use of 'KAMA GEMS' was deceptively similar to the Plaintiff's registered marks, leading to a restraint on selling infringing products and preventing disparagement. Additionally, the court granted several procedural reliefs, including exemption from pre-litigation mediation.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.